Research Roundup: June 23, 2026
- 8 hours ago
- 1 min read
Best of cannabinoid science this week...
In children with autism & severe treatment-resistant behavioral symptoms, a long-term follow-up of CBD found that the initial improvements were maintained or further improved upon, particularly in irritability, social withdrawal & hyperactivity, with a 40% reduction in medication usage
Long-term follow-up of children with autism spectrum disorder and severe treatment-resistant behavioral symptoms treated with purified cannabidiol
In people with anxiety, a diary study of the help they felt from initiating medical cannabis
Beyond symptom change: a qualitative descriptive study of reported quality of life experiences among adults prescribed medicinal cannabis for anxiety disorders https://link.springer.com/article/10.1007/s11096-026-02176-2
In people with PTSD, the use of medical cannabis was linked to a ~35% lower probability of urgent care or emergency department visits
Impact of Medical Cannabis Treatment on Healthcare Utilization Among PTSD Patients: A Retrospective Cohort Study
For muscle health, a review of targeting the endocannabinoid system with CBD
Endocannabinoid system and skeletal muscle health: insights from cannabidiol
In a mouse model of atherosclerosis (hardened arteries), the endocannabinoid oleoylethanolamide (the endocannabinoid of satiation) accelerated plaque removal
Oleoylethanolamide Enhances Regulatory T Cell Function to Accelerate Plaque Regression in Atherosclerosis via PPARα Activation
In a mouse model of liver injury from paracetamol, both cannabis extract & the terpene beta-caryophyllene reduced liver toxicity & improved liver architecture, with the terpene being more effective
Hepatoprotective Effects of β-Caryophyllene and Full-Spectrum Cannabis Extract Against Paracetamol-Induced Liver Injury in Mice
In a mouse model of fentanyl use disorder, the inhalation of CBD lessened addiction & regulated cellular stress & senescence
Cannabidiol (CBD) and Fentanyl
Comments